Founded in California’s Silicon Valley, Solinas Medical is a medical device company dedicated to modernizing vascular access technology for hemodialysis. Their core mission is to address the over $3 billion in costs associated with cannulation-related complications in hemodialysis patients, thereby improving patient outcomes and reducing healthcare expenses. Solinas Medical offers innovative products like the ReTAP AV Graft, designed to enhance the efficiency and safety of vascular access procedures.
Solinas Medical collaborates with leading physicians to drive its innovations. Notable achievements include the development and successful implementation of the ReTAP AV Graft, which has significantly improved the lives of hemodialysis patients by reducing complications. The company's impact is evident in its contributions to lowering healthcare costs and enhancing patient care quality in the hemodialysis market.
